Published in Vaccine Weekly, December 22nd, 2004
The data support the development of Geron's small-molecule telomerase activators for the treatment of patients infected with HIV-1.
The new data was published in the November 15, 2004 issue of the Journal of Immunology and authored by Dr. Rita Effros and colleagues at the department of pathology & laboratory medicine and the University of California, Los Angeles AIDS Institute, David Geffen School of Medicine, Los Angeles,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly